Smith & Nephew plc (SNN)
$27.86+0.69%Close
SELLRECOVERY · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $11.7B
- Beta
- 0.69
- Div yield
- 2.85%
- P/E (TTM)
- 18.30
- Short % float
- 1.11%
- Days to cover
- 4.0
- SI change
- -3.5%
- 1W
- +3.68%
- 1M
- -0.71%
- vs SPY 1W
- +3.82%
- vs SPY 1M
- -3.22%
Industry peers
FMP comparable companies · ranked by market cap
- SYKBUYStryker Corporation$108.3BRECOVERYQ 25$282.60-0.02%
- ZBHSELLZimmer Biomet Holdings, Inc.$17.8BRECOVERYQ 9$92.17-0.10%
- GMEDBUYGlobus Medical, Inc.$10.3BRECOVERYQ 22$76.24+0.10%
- ATECBUYAlphatec Holdings, Inc.$1.7BRECOVERYQ -0$11.25-3.82%
- CNMDSELLCONMED Corporation$1.4BRECOVERYQ 13$45.36+0.42%
- IARTSELLIntegra LifeSciences Holdings Corporation$1.1BCRISISQ 9$13.98-0.93%
- ENOVSELLEnovis Corporation$1.1BRECOVERYQ 0$18.25+4.05%
- KIDSSELLOrthoPediatrics Corp.$567MRECOVERYQ 10$22.08-0.68%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SNN?
- LOPJLB’s latest quantitative signal on Smith & Nephew plc (SNN) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is SNN in?
- Smith & Nephew plc (SNN) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Smith & Nephew plc (SNN) do?
- Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures;…